Point72 Asset Management, L.P.

Position in IMCR — Immunocore Holdings plc

CIK 1603466 STAMFORD, CT

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$33,233,470

+$15,734,389 QoQ

Shares Held

1,102,271

+118.6% QoQ

Ownership

2.17%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,392,275,927 across 187 Biotechnology names. IMCR ranks #21 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$33,233,470	1,102,271	+118.6%	Shares	Defined	2026-05-15
2025-12-31	$17,499,081	504,151	-5.9%	Shares	Defined	2026-02-17
2025-09-30	$19,466,740	535,831	-34.7%	Shares	Defined	2025-11-14
2025-06-30	$25,744,936	820,425	+30.6%	Shares	Defined	2025-08-14
2025-03-31	$18,641,423	628,292	+55.8%	Shares	Defined	2025-07-21
2024-12-31	$11,897,468	403,304	-0.9%	Shares	Defined	2025-02-14
2022-03-31	$12,171,034	407,058	+3182.7%	Shares	Defined	2022-05-16
2021-12-31	$424,576	12,400	-91.7%	Shares	Defined	2022-02-14
2021-09-30	$5,523,430	149,000	+104.4%	Shares	Defined	2021-11-15
2021-06-30	$2,846,745	72,900	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.